* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Spring 1997 - University of Idaho
Survey
Document related concepts
Bisulfite sequencing wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Molecular cloning wikipedia , lookup
Transformation (genetics) wikipedia , lookup
Non-coding DNA wikipedia , lookup
Gel electrophoresis of nucleic acids wikipedia , lookup
Biochemistry wikipedia , lookup
Butyric acid wikipedia , lookup
Point mutation wikipedia , lookup
DNA supercoil wikipedia , lookup
Radical (chemistry) wikipedia , lookup
Biosynthesis wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Specialized pro-resolving mediators wikipedia , lookup
Transcript
A Hypothesis for the Physiological Antioxidant Action of the Salicylates. I. Francis Cheng Department of Chemistry University of Arizona Tucson, Arizona 85721 Tel. (520) 621-6340 [email protected] 1 Seminar Outline A brief history of the salicylates Accepted model for acetylsalicylic (aspirin) action. Weakness of accepted model. Hypothesis for salicylate action. Experiments. Discussion. Proposed Studies. 2 History of Aspirin Plant Based Product Folk remedy for centuries, known to relieve pains and fevers. 1828 - active ingredient isolated by Johann Buchner. Found effective for fevers, inflammation, and pains but found to cause stomach irritation. O OH O O OH OH pKa = 3.0 O CH3 pKa =3.5 1898 - Felix Hofmann (Bayer) synthesizes and tests Acetylsalicylic Acid (Aspirin) Just as effective but less irritating than salicylic acid. 3 Accepted model for acetylsalicylic action. Proposed in the 1970's - John Vane (1982 Nobel Prize) Irreversible inactivation of Prostaglandin Synthase Action. -Key enzyme in the arachidonic acid cascade -Prostaglandins are local hormones that regulate inflammation blood clotting PG consists of two components, Aspirin works on cyclooxygenase. -by acetylation of serine residue. Inhibition of Cyclooxygenase results in reduction of inflammation. Nature-New Biology 264 (1971) pp84-90. 4 Weakness of the acetylation explanation. O OH O O O OH CH3 OH Aspirin Salicylic Acid Vane's Theory Describes The Action of Aspirin But, How Does Salicylic Acid Exert Its Medicinal Action? Lacks an Acetyl Group! Pharmacological Literature Indicates That Salicylic Acid Exerts Antiinflammatory Action Almost as Potent As Acetylsalicylic Acid. Yet Salicylic Acid Lacks an Acetyl Group That Forms the Center Piece of Vane's Theory for Acetylsalicylic Acid 5 Other Weaknesses of the Acetylation Mechanism. Does not explain other documented medicinal effects of aspirin. Aspirin acts as a chemopreventative for...... Heart and circulatory diseases Parkinson’s and Alzheimer’s diseases Cancers Cataracts All of the above may be due to oxidative damage by oxygen containing free radicals. 6 Formation of Activated Oxygen O2.- and H2O2 released as Respiration by-products, [H2O2] = 10-7 [O2.-] = 10-11 Also, Inflammation response (pathogen defense) by white blood cells Physiological oxidative damage linked to chronic inflammation Physiological Reviews, 59 (1979) pp527-605. 7 Goal of Respiration. (CH2O)n + O2 = nCO2 + nH2O Increasing Reducing Pow er (-) (CH 2 O ) n (sugars) E + 1e Redox Potential DG = nFE O2 + 2e .O2 o' (pH7) - 0.45 volts O 2 + 2H + H2O 2 0.30 V + 4e O 2 + 4H (+) + 2H 2O 0.82 V Increasing O xidizing Po wer H2O2 & O2.- are known as “activated oxygen species” 8 Dangers of Activated Oxygen Species Hydrogen peroxide Fenton Reaction H2O2 + FeII(L)n = FeIII(L)n + HO- + HO. HO. + e- = HO- Superoxide ion Eo = 1.8 volts Disproportionation to H2O2 O2.- + O2.- + 2H+ = H2O2 + O2 Reducing agent for Fenton rxn. O2.- + FeIII(L)n = FeII(L)n + O2 Reduces Fe3+(insoluble) to Fe2+ (soluble) physiological evidence indicates that O2.- is may be more toxic than H2O2. 9 Hydroxyl Radical Damage to Biological Molecules Results in ..... Denaturation of lens proteins cataracts DNA strand breakage damage to genes aging cancers mitochondrial dysfunction Fatty acid cross linking circulatory diseases Damage to nervous system Parkinson’s Alzheimer’s diseases Summary Hydroxyl radicals are the likely source of physiological oxidative damage -Scientific American, December 1992, pp131-141. 10 Iron complexes and activated oxygen are conspirators in the oxidative damage to physiological components FeII[complex] + H2O2 = FeIII[complex] + HO- + HO. Fe and disease origins Recently Discovered Statistical Implications in - Heart Diseases - Alzheimer’s - Strokes - Parkinson’s - Cancers - Cataracts Key Point Ailments due to active oxygen forms and iron are closely linked Bioelectrochemistry and Bioenergetics, 18 (1987) pp105-116. Ibid, 18 (1987) pp3-11. Biochemistry, 31 (1992) pp11255-11264. Circulation, 86 (1992) pp803-811. New England Journal of Medicine, 320 (1989) 1012. Iron and Human Disease, CRC Press, Boca Raton, FL, 1992. 11 Migration of Fe Under Conditions of Oxidative Stress H2O2 + O2.Fe Containing Enzymes Oxidized Ligands Fe2+ + ATP, citrate Fe(L) + HO. + H2O2 + O2.Fe(L) 12 Hypothesized Antioxidant Properties of Salicylates. Aspirin may play a role in the moderation of physiological oxidative damage. Hypothesized because of aspirin’s ability to act as a chemopreventative of many diseases associated with oxidative damage. Free Radicals in Biology and Medicine 9, (1990) 299. 13 Proposed Route of Antioxidant Action for Aspirin. (literature) Salicylates act as Hydroxyl Radicals Scavengers. COOH + HO. COOH A) HO + OH OH COOH B) OH OH k 1010 M-1 s-1 Xenobiotica, 18 (1988) pp459-470. 14 Problems with Radical Scavenging Hypothesis. Physiological concentration of aspirin (10-4 M) cannot compete with the oxidative damage to cellular components. Most organics (physiological components) will react with HO. at the same rate as salicylates k = 1010M-1 s-1 (diffusion limited kinetics). Acetaminophen is a more effective hydroxyl radical scavenger. k = 1.5 x 1010 M-1 s-1 lacks - chemopreventative effects - anti-inflammation Summary radical scavenging alone cannot explain the antioxidant characteristics of salicylates. 15 Alternative Hypothesis for Salicylate Antioxidant Behavior. Key Point Salicylates moderate iron activity rather than HO radical scavenging. Salicylate may aid in one or more of the following antioxidant actions I) Redox deactivation of Fe2+/3+ (observed in vitro) II) Superoxide Dismutase Action. III) Catalase Action. 16 Proposed Hypothesis (Continued) I) Storage and Transport of Fe. Redox Deactivation Requires Fenton Inactive Forms (shift Fe2+/3+ threshold to thermodynamically unfavorable potentials) Animals (Humans) - Ferritin, Transferrin Plants & Bacteria - Siderophores II) Superoxide Dismutase (SOD) Action. O2.- + 2H+ + e- = H2O2 III) Catalase Action. 2H2O2 = 2H2O + O2 17 Salicylate as an inhibitor of Fenton processes. Redox Deactivation of Fe2+/3+ Salicylates as chelation agent of iron ions. -may be plant siderophores - iron transport agents Exact structure may vary with pH Hand book of Chemical Equilibria in Analytical Chemistry, Chichester, U.K., Ellis Horwood Limited, 1985, p163. log B3 = 35.5 18 Outline of Experimental Section. Electrochemistry - cyclic voltammetry experiments Tells us something about thermodynamic ability to drive Fenton reaction. DNA oxidations via Fenton reaction. Examine the ability of salicylates to prevent the degradation of calf thymus DNA via Fenton reaction. 19 Redox Potential of Fe-Sal Indicates that it is a Fenton Inactive Complex. FeII[sal] FeIII[sal] + e- Potential versus SHE -0.4 0.4 Eredox = 0.370 volts vs. SHE at pH 7.2 FeII[sal] e- + FeIII[sal] Cyclic voltammogram of iron-salicylate (0.5 mM Ferric Nitrate with 2.0 mM Salicylate) at pH 7.2, 0.05 M phosphate buffer with a potential sweep rate of 5 mV/sec. The electrodes consisted of a 0.071 cm2 wax impregnated graphite disk with a Ag/AgCl, saturated KCl reference (0.197 volts vs. SHE). 20 Salicylate chelates iron into a Fenton inactive form Thermodynamics of the Fenton Reaction Stronger Reducing Agents (-) Fenton Active x Fenton Inactive } EFe[EDTA] EOxidases EOxygenases E0Fenton = 0.307 volts EFe-sal = 0.370 volts 21 Evidence for Fenton Reaction Inertness of Fesalicylate from Cyclic Voltammetry experiments. Electrochemical electrocatalytic wave for FeIII(EDTA) reduction in the presence of H2O2 Electrode: FeIII(EDTA) + e = FeII(EDTA) Solution: FeII(EDTA) + H2O2 = FeIII(EDTA) + HO- + HO. 0.090 volts SHE Results in enhanced electroreduction current for FeIII(EDTA) wave, no electro-oxidation wave for FeII(EDTA) 22 Cyclic Voltammetry of FeII/III [EDTA] in the Absence and Presence of H2O2 -0.7 Potential vs. Ag/AgCl 0.4 mA A A) 0.1 mM FeIII(EDTA) B) +10 mM H2O2. Current B 1.0 mA Potential sweep rate = 5 mV/sec pH 7.2 0.05 M phosphate buffer with a potential sweep rate of 5 mV/sec 0.071 cm2 wax impregnated graphite disk Ag/AgCl, saturated KCl reference (0.197 volts vs. SHE). 23 Results of H2O2 electrocatalytic voltammetry. CuI(EDTA) FeII(sal)3 Potential 0.450 volts 0.370 H2O2 Reduction No No H2O2 = HO- + HO. 0.307 ---- FeII(EDTA) CuI(sal)2 0.090 0.050 Yes Yes Important Predictions. If Redox Deactivation Hypothesis Works Then…. Salicylate acts as an Antioxidant for Fe but not Cu. EDTA acts as an Antioxidant for Cu but not Fe. 24 Important Predictions (continued). If radical scavenging is the predominate mechanism for salicylate antioxidant action then….. Salicylate (k =1010 M-1s-1) will act as a antioxidant for both Fe and Cu EDTA (k = 109 M-1s-1) will act as a antioxidant for both Fe and Cu. 25 DNA as a Probe for Hydroxyl Radical Production. DNA Strand is an efficient chelator of iron and copper ions. Binding Constant 1012 Primarily through phosphate residues DNA-FeII ,- CuI complexes participates in Fenton type chemistries. DNA degradation by .OH (or other oxidizing products) leads to attack on deoxyribose residues which releases bases from strands. Adenine, Thymine, Guanine, Cytosine Products are easily quantifiable by HPLC. UV detection at 254 nm Key Point - DNA strand is a convenient probe for detection of hydroxyl radical. O3PO O Base + .OH H OPO3 O3PO O Base . OPO3 JACS 1992, 114, pp2303-2312. H2O O3PO O Base -PO4 -H HO OPO3 O3PO O Base O + Base H O H O 26 DNA Incubation Studies. Fe-DNA complex Eredox{FeII/III(DNA)} = -0.10 volts SHE FeIII(DNA) + Ascorbate = FeII(DNA) + Deoxyascorbate FeII(DNA) + H2O2 = FeIII(DNA) + HO- + HO. Conditions 0.1 mM Fe(NO3)3, 1.0 mM ascorbate, and 7.8 mM H2O2 DNA (0.2 mM in base pairs), 120 minutes Incubation of DNA with Fe-EDTA FeIII(EDTA) + Ascorbate = FeII(EDTA) + Deoxyascorbate FeII(EDTA) + H2O2 = FeIII(EDTA) + HO- + HO. Conditions 0.1 mM Fe(NO3)3, 0.4 mM EDTA, 1.0 mM ascorbate, and 27 HPLC chromatogram following incubation of calf thymus (CT) DNA A) salicylate absent. B) 0.4 mM salicylate present. Salicylate retards oxidative DNA damage due to Fenton type processes Retention times; Guanine, 1.09 mins.; Thymine, 1.44 mins.; Adenine 2.35 mins Separation conditions: 50/1 water to methanol mobile phase, C18 reversed phase Zorbex cartridge column, absorbance detection at 254 nm. 28 HPLC Detector Response (Thousands) HPLC incubation results 100 80 Thymine 60 Adenine 40 20 0 A B DNA Incubation with… C D A) 0.1 mM Fe(NO3)3 B) 0.1 mM Fe[EDTA] C) 0.1 mM Fe(NO3)3 and 0.4 mM salicylate D) 0.1 mM Fe[EDTA] and 0.4 mM salicylate Salicylate decreases oxidative DNA damage due to Both Fe-DNA and Fe(EDTA) complexes 29 Salicylates may compete for Fe chelation with oxidized EDTA EDTA hydroxyl radical scavenging rate, k = 109 M-1 s-1 Under inflamed conditions Fe undergoes migration due to oxidative attack of low molecular weight ligands 30 Summary of DNA Incubation Experiments. Control Incubation-10 Minutes Damage to CT-DNA 0.5 mM Ascorbate 5.0 mM H2O2 NO + 0.1 mM Fe(EDTA) + 0.1 mM Cu(EDTA) YES NO + 0.1 mM Fe(salicylate) + 0.1 mM Cu(salicylate) NO YES Confirms Redox deactivation hypothesis 31 Summary of DNA Incubation Experiments Excess Ligand (salicylate or EDTA) Control Incubation 10 minutes Damage to CT-DNA 0.5 mM Ascorbate 5.0 mM H2O2 NO + 0.1 mM Cu(salicylate) + 10.0 mM salicylate YES + 0.1 mM Fe(EDTA) + 50.0 mM EDTA YES Indicates that radical scavenging is not an important mechanism. 32 Incubation Results with Aspirin Acetylsalicylic acid cannot chelate iron – slowly hydrolyzes to salicylic acid (t1/2 = 20 min.) – Radical scavenging rates; aspirin = salicylate Control Incubation 10 minutes CT-Damage 0.5 mM Ascorbate 5.0 mM H2O2 NO + 0.1 mM Fe(NO3)3 + 0.4 mM aspirin YES 33 Release of adenine with incubation time for controls, and presence of salicylate, and aspirin. Adenine Release – Less than 10 minutes – Greater than 60 minutes aspirin = control aspirin = salicylic acid HPLC Detector Response (254 nm) Results consistent with acetylsalicylic acid to salicylic acid Control Salicylic Acid Acetylsalicylic Acid 0 20 40 Incubation Time (min) 100 34 Outline of Discussion Role of pH in the Fenton Reaction • Implications in inflammation and cancer pH and the FeII/III[salicylate] redox potential • This is a key feature in salicylate’s antioxidant ability 35 The role of H+ activity and physiological oxidative damage. Fenton Reaction is pH sensitive H2O2 + e- = HO- + HO. EFenton = 0.732 -(0.059 pH) where [H2O2] = [HO.] = 1 at pH 7.2 EFenton = 0.307 volts SHE at pH 5.5 EFenton = 0.408 volts SHE Fenton threshold becomes more facile with decreasing pH. Important consideration Inflamed, damaged, or tumorous tissues may reach pH’s as low as 3.5 36 FeII/III[salicylate] potential is pH dependent. Potential (volts vs. SHE) 2 EFe(sal) = 0.793 - (0.059 pH) 1 0 2 4 6 8 10 pH Measured by Cyclic Voltammetry 37 pH dependence may be due to HO- complexation FeIII(sal)n + HO- = FeIIIOH(sal)n FeIIIOH(sal)n + e- = FeII(sal)n + HOIII RT [ Fe ( - OH )( sal ) n ] 0 E=E + ln II nF [ Fe ( sal ) n ][ HO ] E = const - 0.059 pH E = 0.793 - 0.059 pH 38 Fenton threshold and the FeII/III(sal) redox potential Potential (volts SHE) 2 1.5 E0Fe-Sal = 0.793 - 0.059pH 1 0.5 E0Fenton = 0.732 - 0.059pH 0 0 2 4 6 8 10 pH FeII/III(sal) redox potential closely parallels EoFenton – Remains just slightly thermodynamically uphill Why does salicylic acid not seek to maximize Fe deactivation? – By increasing FeII/III potential 39 Hypothesis Possible Significance of the close parallel of Fe II/III(sal)n and Standard State Fenton threshold. 2 Superoxide Dismutation Superoxide Dismutation. Zone I 1.5 O2.- + 2H+ + e- = H2O2 Eo = 1.77 volts 1 EFe-Sal E = 1.77 + 2(0.059)pH Salicylic acid may seek to maximize SOD activity with a minimum of Fenton type reactivity. 0.5 Zone II Fenton Threshold Zone III 0 0 2 4 6 8 10 pH 40 Thermodynamic Suppression of HO. Production by Salicylate. Reduction: H2O2 + e = HO- + HO. Oxidation: FeII(sal)n = FeIII(sal)n + e Ecell = Ered - Eox Ered [ H 2 O2 ] = 0.732 - 0.0591 pH + 0.0591log [ HO. ] Eox = 0.793 - 0.0591pH Calculate equilibrium value for product/reactant ratio @ pH 7 (Ecell= 0) [ HO . ] = 0.0928 [ H 2O 2] Healthy Tissue Maintains [H2O2] = 10-9 - 10-7 (Physiological Reviews, 59 (1979) p564.) Salicylic acid is a modest suppression agent of HO. 41 Thermodynamic Analysis of Superoxide Dismutase Activity of Iron-Salicylate Reduction: O2.- + 2H+ + e- = H2O2 Oxidation: FeII[sal] = FeIII[sal] + eEcell = Ered - Eox .[O 2 ] Ered = 1.77 - 0.118 pH + 0.0591 log [H2O2] Eox = 0.793 - 0.0591 pH @ pH 7 Ecell Spontaneous until [ O2.- ] = 2.94 x10- 10 [ H 2 O2 ] Salicylic acid may be an excellent suppression agent of O2.42 Equilibrium SOD and Fenton Ratios vs. Iron Chelate Redox Potential Equilibrium values (from Nernst equation) for SOD action and Fenton reaction moderation as a function of the redox potential of FeII/III transition of a chelate. pH 7 10 10 FeII/III[salicylate] Fenton Rxn Moderation . [ HO ] log [ H 2 O2 ] 5 5 0 0 -5 -5 -10 -10 -15 -15 -20 -20 -0.1 0.1 0.3 0.5 0.7 0.9 1.1 1.3 Redox Potential of Chelated Iron (SHE) SOD Action [O2.- ] log [ H 2 O2 ] 43 Conclusions Antioxidant Action via Suppression of Fenton Reaction. Redox inactivation, E = 0.793 - 0.059pH, rather than HO. radical scavenging DNA Oxidation Studies with Fe2+/3+and Cu1+/2+ with salicylate and EDTA. 44 Future Research Binding constant data, function of pH, potentiometric titrations Crystal structure of iron-salicylate complex Superoxide dismutase (SOD) action. Catalase action H2O2 + 2H+ + 2e- = 2H2O H2O2 = O2 + 2H+ + 2e2H2O2 = 2H2O + O2 -qualitatively observed during DNA oxidation studies. Prediction of Structure-Activity Relationships -antioxidant characteristics of other NSAID, (ibuprofen) -increase activity of salicylates -quick screen for antioxidant characteristics of newly isolated natural products Collaborative Research -physiological Studies 45 Quantitative Structure-Activity Relationships (QSAR) for Salicylates and Derivatives (Anti-inflammatory action) Rule 1. Substitution on either the carboxyl or the phenolic hydroxyl groups affect activity. Rule 2. Placing the phenolic hydroxyl group meta or para to the carboxyl group abolishes activity. Rule 3. Substitution of halogen atoms on the aromatic ring enhances potency. Rule 4. Substitution of aromatic rings meta to the to the carboxyl and para to the phenolic hydroxyl groups increases anti-inflammatory 46 activity. Rule 1. Substitution on either the carboxyl or the phenolic hydroxyl groups affect activity. May Affect Chelation of Fe ions. Binding Constant to Fe Rate of hydrolysis to salicylate O OH O O OH OH salicylic acid O CH3 acetylsalicylic acid 47 Rule 2. Placing the phenolic hydroxyl group meta or para to the carboxyl group abolishes activity. Meta and Para derivatives are not Fe chelators Bidentate Chelation Site COOH COOH COOH HO OH OH Salicylic Acid 3-hydroxyl benzoic acid 5-hydroxyl benzoic acid 48 Rule 3. Substitution of halogen atoms on the aromatic ring enhances potency. Rule 4. Substitution of aromatic rings meta to the to the carboxyl and para to the phenolic hydroxyl groups increases anti-inflammatory activity. Increases electron withdrawing ability of salicylate raises FeII/III potential COO e- Fe II O May improve Fenton deactivation 49 If Fe chelation correlates to QSAR anti-inflammatory rules ??? Anti-inflammatory action = Antioxidant action ??? 50 Other anti-inflammatory agents All of the following NSAID’s are iron chelation agents. Iron chelation may play a role in their medicinal action. OH COOH CONH2 R3 Cl O N NH OH N O R1 S O Salicylamide R2 Mefenamic Acid, R1 = R2 = CH3, R3 = H Meclofenamic Acid, R1 = R3 = Cl, R3 = CH3 Flufenamic Acid, R1 = R3 = H, R3 = CF3 N H CH3 N CH3 O H3CO Piroxicam CH2COOH Indomethacin N-ayrlanthranilic Acids 51 Acknowledgments Seton Hall University Graduate Students (M.S.) Andris Amolins Chris Zhao Undergraduates Malgorzata Galazka Leon Doneski University of Arizona Dr. Quintus Fernando Dr. Paul Oram Equipment Ciba-Giegy Union-Camp FMC 52